PRESS RELEASE published on 01/09/2025 at 09:00, 1 year 6 months ago Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA) Biotest AG reaches a significant milestone by submitting a Biologics License Application for Fibrinogen to the US FDA, aiming to address fibrinogen deficiency FDA Biotest AG Fibrinogen Biologics License Application Medical Treatment
BRIEF published on 11/15/2024 at 09:05, 1 year 8 months ago Minister and Mayor Advocate for Plasma Donations at Biotest's Center Biotest AG Public Awareness Plasma Donations Darmstadt Healthcare Employment
BRIEF published on 11/15/2024 at 09:05, 1 year 8 months ago Le ministre et le maire plaident en faveur des dons de plasma au centre Biotest Biotest AG Sensibilisation Du Public Darmstadt Dons De Plasma Emploi Dans Le Secteur De La Santé
PRESS RELEASE published on 11/15/2024 at 09:00, 1 year 8 months ago Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt and call for plasma donations Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt to promote plasma donations and secure the long-term supply of plasma. Biotest AG emphasizes the importance of plasma donation in treating various illnesses Community Support Healthcare Biotest AG Plasma Donations Plasma Center
BRIEF published on 11/14/2024 at 10:19, 1 year 8 months ago Biotest Reports 4.5% Revenue Increase in First Nine Months of 2024 Financial Outlook Biotest Revenue Yimmugo® Growth Fibrinogen BT524 Grifols Agreement
BRIEF published on 11/14/2024 at 10:19, 1 year 8 months ago Biotest annonce une augmentation de son chiffre d'affaires de 4,5 % au cours des neuf premiers mois de 2024 Perspectives Financières Chiffre D'affaires De Biotest Croissance De Yimmugo® Fibrinogène BT524 Accord Grifols
PRESS RELEASE published on 11/14/2024 at 10:14, 1 year 8 months ago Biotest increases revenues in the first 9 months by 4.5% to Euro 523 million Biotest AG reports 4.5% revenue growth in first 9 months, reaching Euro 523 million. Product sales rise by 13.7%. Adjusted EBIT remains stable. Marketing authorization application submitted for Fibrinogen Concentrate (BT524). Outlook adjusted Revenue Growth EBIT Biotest AG Product Sales Marketing Authorization
BRIEF published on 11/14/2024 at 09:01, 1 year 8 months ago Biotest AG Revises Revenue, Cash Flow, and ROCE Forecasts for 2024 Revenue Growth Financial Forecast Biotest AG ROCE EBIT Guidance
BRIEF published on 11/14/2024 at 09:01, 1 year 8 months ago Biotest AG révise ses prévisions de revenus, de flux de trésorerie et de ROCE pour 2024 Biotest AG ROCE Prévisions Financières Croissance Des Revenus Prévisions EBIT
PRESS RELEASE published on 11/14/2024 at 08:56, 1 year 8 months ago EQS-Adhoc: Biotest AG: Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged Biotest AG corrects forecast for revenue, cash flow, and ROCE while maintaining EBIT guidance. Details on the adjustments made for the 2024 financial year disclosed Revenue Cash Flow Biotest AG ROCE Forecast Correction
Published on 08/07/2026 at 13:00, 55 minutes ago Gold Terra Announces Start of Drilling on the Campbell Shear Northern Zone 103N Extension to Expand 2026 MRE of Inferred 595,000 Ounces, Con Mine, Yellowknife, NWT
Published on 08/07/2026 at 00:45, 13 hours 10 minutes ago NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 14 hours 40 minutes ago LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 15 hours 40 minutes ago Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 15 hours 50 minutes ago Innodata Reports Record Second Quarter 2026 Results
Published on 08/07/2026 at 13:30, 25 minutes ago Alphawave: New NC 6.1 Trading Model Starts Q3 2026 with +19.36%
Published on 08/07/2026 at 12:05, 1 hour 49 minutes ago Genel Energy PLC: Response to announcement made by DNO ASA
Published on 08/07/2026 at 11:12, 2 hours 43 minutes ago EQS-Adhoc: Asklepios Kliniken GmbH & Co. KGaA submits request for the implementation of a squeeze-out of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft
Published on 08/07/2026 at 11:00, 2 hours 54 minutes ago MuniFin Group’s Half Year Report January–June 2026 is published
Published on 08/07/2026 at 11:00, 2 hours 55 minutes ago PWO Group generates new business of EUR 363m and increases free cash flow in the first half of 2026
Published on 08/07/2026 at 08:30, 5 hours 25 minutes ago Disclosure of shares outstanding and voting rights - 07.08.2026
Published on 08/07/2026 at 08:30, 5 hours 25 minutes ago Déclaration nombre d'actions et droits de vote - 07.08.2026
Published on 08/06/2026 at 18:26, 19 hours 29 minutes ago Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 18:26, 19 hours 29 minutes ago Air Liquide droits de vote au 31 juillet 2026
Published on 08/06/2026 at 17:46, 20 hours 9 minutes ago Déclaration des droits de vote à fin juillet 2026